Sweat but No Gain: Inhibiting Proliferation of Multidrug Resistant Cancer Cells With “Ersatzdroges”

International Journal of Cancer - United States
doi 10.1002/ijc.29158
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Nanomicellar Paclitaxel Increases Cytotoxicity of Multidrug Resistant Breast Cancer Cells

Cancer Letters
Cancer ResearchOncology
2009English

Synergistic Effect of Vitamin C With Cisplatin for Inhibiting Proliferation of Gastric Cancer Cells

Iranian Biomedical Journal
BiochemistryClinical BiochemistryGeneticsMolecular Biology
2020English

Interaction of Multidrug-Resistant Chinese Hamster Ovary Cells With Amphiphiles

British Journal of Cancer
Cancer ResearchOncology
1993English

Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection With Multidrug-Resistant Enterobacteriaceae

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2016English

Danazol Mediates Collateral Sensitivity via STAT3/Myc Related Pathway in Multidrug-Resistant Cancer Cells

Scientific Reports
Multidisciplinary
2019English

Inhibiting PAD2 Enhances the Anti-Tumor Effect of Docetaxel in Tamoxifen-Resistant Breast Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

MicroRNA-375 Regulates Proliferation and Apoptosis of Glioma Cancer Cells by Inhibiting CTGF-EGFR Signaling Pathway

Bratislava Medical Journal
2018English

Multidrug Resistant Tuberculosis

British Medical Journal
Medicine
2015English

CXL146, a Novel 4h-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug Resistant Cancer Cells

Molecular Pharmacology
Molecular MedicinePharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy